NCT01161771

Brief Summary

This is a multicenter evaluation of the effects of the cataract extraction and limbal relaxing incisions (LRI) on corneal sensation and dry eye signs and symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 6, 2010

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 14, 2010

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

July 26, 2012

Completed
Last Updated

July 26, 2012

Status Verified

July 1, 2012

Enrollment Period

7 months

First QC Date

July 6, 2010

Results QC Date

December 13, 2011

Last Update Submit

July 17, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Percentage of Subjects at Month 3 With Corneal Sensitivity < 50 Millimeters (mm) at Any of the Locations Measured

    The percentage of subjects at month 3 with corneal sensitivity \< 50 mm at any of the locations measured. Corneal sensitivity is evaluated by using a nylon filament to measure the capability of the cornea (clear front portion of the eye) to respond to touch. The longest filament length at which a minimum of the 3 out of 5 stimulus applications produce a positive response from the subject was the corneal touch threshold (sensitivity). Measurements were taken at 5 different locations in each cornea.

    Month 3

Secondary Outcomes (5)

  • Change From Baseline in Ocular Surface Disease Index (OSDI) Total Score at Month 3

    Baseline, Month 3

  • Change From Baseline in Corneal Staining at Month 3

    Baseline, Month 3

  • Change From Baseline in Conjunctival Staining at Month 3

    Baseline, Month 3

  • Change From Baseline in Tear Break-Up Time at Month 3

    Baseline, Month 3

  • Change From Baseline in Schirmer's Test at Month 3

    Baseline, Month 3

Study Arms (1)

Patients with cataract and corneal astigmatism

Patients with cataract(s) and corneal astigmatism who received surgical treatment (cataract extraction and limbal-relaxing incisions)

Procedure: Cataract Surgery and Limbal relaxing incision

Interventions

Cataract extraction and limbal-relaxing incisions

Patients with cataract and corneal astigmatism

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing cataract extraction and limbal relaxing incision

You may qualify if:

  • Patient scheduled to undergo clear corneal cataract extraction with planned limbal relaxing incision for correction of a corneal astigmatism

You may not qualify if:

  • Uncontrolled systemic disease
  • Have undergone refractive surgery or any surgery involving a limbal or corneal incision
  • Use of topical cyclosporine (Restasis) within three months of baseline/randomization visit
  • Temporary or permanent occlusion of the lacrimal puncta

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unknown Facility

Long Island City, New York, United States

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Interventions

Cataract Extraction

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Results Point of Contact

Title
Vice President, Global Medical Affairs
Organization
Allergan, Inc.

Study Officials

  • Medical Director

    Allergan

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2010

First Posted

July 14, 2010

Study Start

May 1, 2010

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

July 26, 2012

Results First Posted

July 26, 2012

Record last verified: 2012-07

Locations